drjobs Head of Biosafety, Non-clinical and Emerging Technologies

Head of Biosafety, Non-clinical and Emerging Technologies

Employer Active

1 Vacancy
drjobs

Job Alert

You will be updated with latest job alerts via email
Valid email field required
Send jobs
Send me jobs like this
drjobs

Job Alert

You will be updated with latest job alerts via email

Valid email field required
Send jobs
Job Location drjobs

London - UK

Monthly Salary drjobs

Not Disclosed

drjobs

Salary Not Disclosed

Vacancy

1 Vacancy

Job Description

Description

We are currently looking for a Head of Biosafety Non-Clinical & Emerging Technologies to join our Benefit Risk Evaluation I Team within the Safety & Surveillance group.

This is a full-time opportunity on a permanent basis. The role will be based in 10 South Colonnade Canary Wharf London E14 4PU. Please be aware that this role can only be worked in the UK and not overseas.

Government departments and agencies are working towards implementing a minimum 60% attendance in office sites.

We are currently implementing a flexible hybrid way of working with a minimum of 8 days per month working on site to enable the collaboration and contact with partners and stakeholders needed to deliver MHRA business. Attendance on site is driven by business needs so depending on the nature of the role this can flex up to 12 days a month with the remainder of time worked either remotely or in the office. Some roles will need to be on site more regularly.

Who are we

The Medicines and Healthcare products Regulatory Agency enhance and improve the health of millions of people every day through the effective regulation of medicines and medical devices underpinned by science and research.

The Safety and Surveillance (S&S) Group brings together into a single integrated structure expertise on the safety of all medical products with enforcement capabilities. These functions are supported by the Agencys data and evidence generating capabilities complementing our signal generating abilities.

Against this background and the drive to improve treatment availability for patients safety remains at the heart of all our decision making across the product life cycle. The central mission of the Safety & Surveillance portfolio is to protect the public by appropriately identifying assessing and managing the risks associated with medical products. In every aspect of this work we harness the best science technology information and professional practice to protect patients in new and impactful ways.

Whats the role

We are looking for an ambitious forward-thinking leader to head the Biosafety Non-Clinical & Emerging Technologies team. The role will suit an experienced clinician academic or regulatory specialist with expertise in pre-clinical assessment toxicology genomics or in vitro diagnostics and an interest in protecting patient safety. This role presents a unique opportunity to lead a dynamic cross-disciplinary group focused on the cutting-edge intersection of medicines devices and evolving therapeutic modalities.

The post holder will lead the integration of scientific clinical and technical expertise to deliver high-quality benefit-risk assessments and ensure effective matrix working across the Benefit-Risk Evaluation functions the wider Safety and Surveillance Group and Agency lifecycle group. The role is pivotal in ensuring timely and robust responses to potential safety concerns directly informing evidence-based regulatory decisions that uphold public health and product performance standards.

In this role you will lead critical activities related to:

Key responsibilities:

  • Non-clinical toxicology: support for toxicological genotoxicity carcinogenicity and reproductive toxicity assessments in the safety of medicines including in silico modelling to enhance safety evaluations.
  • Biological safety and sterilisation and decontamination assessment: underpinning both post-market surveillance and clinical investigations for medical devices.
  • Pharmacogenomics for pharmacovigilance: co-ordinate policy on the integration of pharmacogenomics with pharmacovigilance to support personalised medicine ensuring our approach remains at the forefront of healthcare.
  • Emerging technologies: lead policy on post-market surveillance and risk assessment of diagnostics as well as emerging and advanced technologies such as nano-enabled medicines and devices ATMPs (Advanced Therapy Medicinal Products) and synthetic biology products.

Who are we looking for

Oursuccessful candidatewill have:

  • Experience in pre-clinical assessment toxicology genomics or diagnostics; this is essential.
  • Experience of working at a senior level communicating effectively with a range of senior level stakeholders is essential.
  • Experience of leading and/or managing diverse multidisciplinary teams and work programmes to deliver results to tight deadlines.
  • Expertise in the relevant clinical scientific academic or technical field including evidence of up-to-date specialist level of knowledge and evidence of analysis of data and preparation of reports scientific publications or reviews or manuscripts for regulatory submissions is essential.
  • Delivering at Pace: Evidence of ability to work in a pressurised target driven environment delivering results on time within a range of deadlines maintaining high standards of quality.

If you would like to find out more about this fantastic opportunity please read our Job Description and Person Specification!




Required Experience:

Director

Employment Type

Full-Time

Report This Job
Disclaimer: Drjobpro.com is only a platform that connects job seekers and employers. Applicants are advised to conduct their own independent research into the credentials of the prospective employer.We always make certain that our clients do not endorse any request for money payments, thus we advise against sharing any personal or bank-related information with any third party. If you suspect fraud or malpractice, please contact us via contact us page.